Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Publications
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
All Publications
Filter:
Program
Medical Countermeasures
Opioid Antagonist
Filter
July 19, 2026
A Phase 1, Open-Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants
Read More
April 1, 2026
Improving Inferences Regarding Patient Events Using Emergency Medical Services Response-Based Data
Read More
May 10, 2024
Naloxone Distribution Programs in the Emergency Department: A Scoping Review of the Literature
Read More
May 6, 2016
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
Read More
